Stefan Vitorovic

Stefan Vitorovic General Information

Biography

Mr. Stefan Vitorovic co-founded and served as Managing Director at Vida Ventures (Boston). Mr. Vitorovic also serves as Board Member at Vigil Neuro. Before founding Vida Ventures, He was an investment professional at Third Rock Ventures, an early-stage life sciences venture capital firm. At Third Rock, he focused on new company formation, due diligence, portfolio company financings, and partner development. He was part of the founding team of Decibel Therapeutics, a hearing-focused drug discovery and development platform company. Before Third Rock, he was an investor at TPG Capital, where he focused primarily on majority, control stakes in healthcare companies. He worked on a variety of equity and debt financings, including Aptalis Pharma and Biomet. Before TPG, he was an investment banker at Credit Suisse's healthcare banking group. There he primarily focused on M&A and equity financings for pre-commercial life sciences companies. He received his B.S. with Honors in Biological Sciences at Stanford University. He completed his M.S. in Biology at Stanford, where he conducted biomedical research in the lab of Dr. Helen Blau at Stanford Medical School. He later received his MBA from Harvard Business School. He currently serves on the Board of Directors for Praxis Precision Medicines and BAIT Cellular Therapeutics and as a Board Observer for Oyster Point Therapeutics. He serves as a Board Member of the New England Venture Capital Association.